Literature DB >> 3018581

Tissue-specific expression of the human tropomyosin gene involved in the generation of the trk oncogene.

F C Reinach, A R MacLeod.   

Abstract

The trk oncogene is a human transforming gene generated by the fusion of tropomyosin gene sequence to a truncated tyrosine kinase receptor gene. We have now characterized the normal tropomyosin gene from which the trk oncogene is derived. At least two different transcripts are expressed by this gene using a tissue-specific alternative messenger RNA splicing mechanism: a 2.5-kilobase (kb) mRNA encoding a 248-amino-acid tropomyosin in human fibroblasts and a 1.3-kb mRNA encoding a 285-amino-acid tropomyosin in human skeletal muscle. The rearrangement which generates the trk oncogene preserves most of the tropomyosin-coding sequences of the normal gene, including exons alternatively spliced in muscle and non-muscle tissue. We therefore expect the trk oncogene to show a tissue-specific pattern of transforming activity. Correct expression of the trk oncogene can occur only in non-muscle tissues. In muscle tissue the oncogene would almost certainly be inactive, as splicing according to the alternative muscle pattern aborts synthesis of the tyrosine kinase domain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018581     DOI: 10.1038/322648a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  15 in total

1.  Separation and identification of differentially expressed nuclear matrix proteins between human esophageal immortalized and carcinomatous cell lines.

Authors:  Xing-Dong Xiong; En-Min Li; Li-Yan Xu; Hai-Bin Chen; Ling Chen; Wei-Jia Cai; Ya-Li Han; Zhong-Ying Shen; Yi Zeng
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  The rat alpha-tropomyosin gene generates a minimum of six different mRNAs coding for striated, smooth, and nonmuscle isoforms by alternative splicing.

Authors:  D F Wieczorek; C W Smith; B Nadal-Ginard
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

3.  The mRNA and RNA-copy pseudogenes encoding TM30nm, a human cytoskeletal tropomyosin.

Authors:  A R MacLeod; C Houlker; F C Reinach; K Talbot
Journal:  Nucleic Acids Res       Date:  1986-11-11       Impact factor: 16.971

4.  Human hTM alpha gene: expression in muscle and nonmuscle tissue.

Authors:  A R MacLeod; C Gooding
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

5.  Cloning and characterization of a cDNA encoding transformation-sensitive tropomyosin isoform 3 from tumorigenic human fibroblasts.

Authors:  C S Lin; J Leavitt
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

6.  Alteration of tropomyosin function and folding by a nemaline myopathy-causing mutation.

Authors:  J Moraczewska; N J Greenfield; Y Liu; S E Hitchcock-DeGregori
Journal:  Biophys J       Date:  2000-12       Impact factor: 4.033

7.  Avian tropomyosin gene expression.

Authors:  G J Lindquester; J E Flach; D E Fleenor; K H Hickman; R B Devlin
Journal:  Nucleic Acids Res       Date:  1989-03-11       Impact factor: 16.971

8.  TaqI RFLP of the human tropomyosin gene (TPM3) involved in the generation of the TRK oncogene.

Authors:  P Michieli; M A Pierotti; V De Benedetti; R Donghi; P Mondini; P Radice; G Della Porta
Journal:  Nucleic Acids Res       Date:  1991-09-11       Impact factor: 16.971

9.  Evolution of tropomyosin functional domains: differential splicing and genomic constraints.

Authors:  S Colote; J S Widada; C Ferraz; F Bonhomme; J Marti; J P Liautard
Journal:  J Mol Evol       Date:  1988       Impact factor: 2.395

10.  Cis requirements for alternative splicing of the cardiac troponin T pre-mRNA.

Authors:  T A Cooper; M H Cardone; C P Ordahl
Journal:  Nucleic Acids Res       Date:  1988-09-12       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.